Citations

Institution: Mayo Clinic Clear

Showing 10 of 108104 citations.

Comparison of Natural Language Processing Biosurveillance Methods for Identifying Influenza From Encounter Notes
Froehling, David A. , Wahner‐Roedler, Dietlind L. , Brown, Steven H. , Bailey, Kent R., Elkin, Peter L.

Annals of Internal Medicine | April 12, 2013 | Volume: 156 | Issue: 1_Part_1 | Pages: 11-18

10.7326/0003-4819-156-1-201201030-00003 | PMID 22213490 Get It

Serologic Testing for Lyme Disease
Duffy, Joseph, Mertz, Lester E.

Annals of Internal Medicine | April 12, 2013 | Volume: 103 | Issue: 3 | Pages: 458-458

10.7326/0003-4819-103-3-458 | PMID 4026091 Get It

Athletic Women, Amenorrhea, and Skeletal Integrity
Heath, Hunter

Annals of Internal Medicine | April 12, 2013 | Volume: 102 | Issue: 2 | Pages: 258-260

10.7326/0003-4819-102-2-258 | PMID 3966762 Get It

Delayed Air Embolism After Removal of Venous Catheters
Hanley, Peter C., CLICK, ROGER L., TANCREDI, ROBERT G., CLICK, ROGER L., TANCREDI, ROBERT G.

Annals of Internal Medicine | April 12, 2013 | Volume: 101 | Issue: 3 | Pages: 401-402

10.7326/0003-4819-101-3-401_2 | PMID 6465714 Get It

What Distinguishes Top-Performing Hospitals in Acute Myocardial Infarction Mortality Rates?
Curry, Leslie , Cherlin, Emily , Thompson, Jennifer W., Berg, David N., Ting, Henry H. , Decker, Carole, Bradley, Elizabeth H. , Spatz, Erica S. , Krumholz, Harlan M.

Annals of Internal Medicine | April 12, 2013 | Volume: 154 | Issue: 6 | Pages: 384-390

10.7326/0003-4819-154-6-201103150-00003 | PMID 21403074 Get It

Tamoxifen Therapy for Metastatic Carcinoid Tumor: A Negative Study
Moertel, Charles G., ENGSTROM, PAUL F., SCHUTT, ALLAN J., ENGSTROM, PAUL F., SCHUTT, ALLAN J.

Annals of Internal Medicine | April 12, 2013 | Volume: 100 | Issue: 4 | Pages: 531-532

10.7326/0003-4819-100-4-531 | PMID 6200021 Get It

Weight Standards: Their Clinical Significance
Callaway, C. Wayne

Annals of Internal Medicine | April 12, 2013 | Volume: 100 | Issue: 2 | Pages: 296-298

10.7326/0003-4819-100-2-296 | PMID 6691671 Get It

The Association Between Age and Nephrosclerosis on Renal Biopsy Among Healthy Adults
Amer, Hatem , Cornell, Lynn D. , Taler, Sandra J. , Cosio, Fernando G., Kremers, Walter K. , Textor, Stephen C., Stegall, Mark D. , Rule, Andrew D. , Stegall, Mark D , Amer, Hatem , Cornell, Lynn , Kremers, Walter K

Annals of Internal Medicine | April 12, 2013 | Volume: 152 | Issue: 9 | Pages: 561-567

10.7326/0003-4819-152-9-201005040-00006 | PMID 20439574 Get It

Effect of body mass index on tumor characteristics and disease‐free survival in patients from the HER2‐positive adjuvant trastuzumab trial N9831
Crozier, Jennifer A. , Moreno‐Aspitia, Alvaro , Ballman, Karla V. , Dueck, Amylou C. , Pockaj, Barbara A. , Perez, Edith A. , Dueck, A. C. , Ballman, Karla

Cancer | April 12, 2013 | Volume: 119 | Issue: 13 | Pages: 2447-2454

10.1002/cncr.28051 | PMID 23585192 Get It

BACKGROUNDData suggest that weight, and specifically body mass index (BMI), plays a role in breast cancer development and outcome. The authors hypothesized that there would be a correlation between BMI and clinical outcome in patients with early stage, human epidermal receptor 2 (HER2)‐positive breast cancer enrolled in the N9831 adjuvant trial.METHODSPatients were grouped according to baseline BMI as follows: normal (BMI <25 kg/m2), overweight (BMI ≥25 kg/m2 and <30 kg/m2), and obese (BMI ≥30 kg/m2). Disease‐free survival (DFS) was estimated using the Kaplan‐Meier method. Comparisons between treatment arms A, B, and C (chemotherapy with or without trastuzumab) were performed using a stratified Cox proportional hazards model.RESULTSAnalysis was completed on 3017 eligible patients. Obese patients were more likely to be older and postmenopausal (P < .0001 for both), to have larger tumors (P = .002), and to have positive lymph nodes (P = .004). In the pooled analysis cohort, differences in DFS among the BMI groups were statistically significant (5‐year DFS rate: 82.5%, 78.6%, and 78.5% for normal weight, overweight, and obese women, respectively; log‐rank P = .02). The adjusted hazard ratio comparing the DFS of overweight women with the DFS of normal women was 1.30 (95% confidence interval, 1.06‐1.61); and, comparing the DFS of obese women with the DFS normal women, the adjusted hazard ratio was 1.31 (95% confidence interval, 1.07‐1.59). There were no statistically significant differences in DFS by weight group for women within any trial arm.CONCLUSIONSPatients with early stage, HER2‐positive breast cancer and normal BMI had a better 5‐year DFS compared with overweight and obese women. The current results indicated that adjuvant trastuzumab improves clinical outcome regardless of BMI. Cancer 2013;119:2447‐2454. © 2013 American Cancer Society.
Progress Against Osteoporosis
Heath, Hunter

Annals of Internal Medicine | April 12, 2013 | Volume: 98 | Issue: 6 | Pages: 1011-1013

10.7326/0003-4819-98-6-1011 | PMID 6859683 Get It